HIV treatment outcomes in Europe and North America: What can we learn from the differences?

Expert Review of Anti-Infective Therapy

Volumn 12, Issue 5, 2014, Pages 523-526

  Ambrosioni, Juan ^a,b   Nicolas, David ^a   Agüero, Fernando ^a   Manzardo, Christian ^a   Miro, Jose M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

access to antiretroviral therapy; antiretroviral treatment; cascade of care; Europe; HIV infection; HIV testing; North America; outcome; retention in care; treatment as prevention

Indexed keywords

BIOLOGICAL MARKER; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BIOPSY; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; EXTRAPULMONARY TUBERCULOSIS; GOLD STANDARD; HISTOLOGY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LIQUID CULTURE; MEDICAL HISTORY; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; NUCLEIC ACID AMPLIFICATION; REVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOUS ARTHRITIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; UROGENITAL TUBERCULOSIS; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; DRUG EFFECTS; EPIDEMIOLOGY; EUROPE; HEALTH CARE DELIVERY; HIV INFECTIONS; NORTH AMERICA; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DELIVERY OF HEALTH CARE; EUROPE; HIV INFECTIONS; HUMANS; NORTH AMERICA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84898954742     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2014.906900     Document Type: Review

References (20)

1. WHO regional offices. Available from: http://www.who.int/about/regions/ en/
2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available from: http://aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf [Last accessed 30 August 2013]
3. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012;308(4):387-402
4. The European AIDS Clinical Society (EACS). European Guidelines for treatment of HIV infected adults in Europe (vs 7.0 October 2013). Available from: www.eacsociety.org/Portals/0/Guidelines-Online-131014.pdf [Last accessed 23 October 2013]
5. WHO Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (Kuala Lumpur June 2013). Available from: www.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf [Last accessed 30 August 2013]
6. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006; 55(No. RR-14):1-17
7. Delpech V. Reducing onward transmission: Viral suppression among key population groups living with HIV in the United Kingdom. 19th Annual Conference of the British HIV Association (BHIVA); April 2013; Manchester, UK
8. Supervie V, Ndawinz J, Costagliola D. How to estimate the size of the hidden HIV epidemic? The case of France. HIV in Europe 2012 Conference. October 2012; Copenhagen, Denmark
9. Esteve A. La contribucio'n de la Cohorte PISCIS a la Vigilancia Epidemiolo'gica y a la Cascada de Servicios en Cataluna. XI International AIDS Impact Conference and XVI Spanish National Conference of AIDS; September 2013; Barcelona, Spain
10. Montaner JS. [Adverse consequences for the human immunodeficiency virus epidemic in Spain following the new legal health framework on the illegal immigrants - save today and pay more tomorrow]. Enferm Infecc Microbiol Clin 2012;30(8):431-2
11. Perez-Molina JA, Pulido OF. [Assessment of the impact of the new health legislation on illegal immigrants in Spain: the case of human immunodeficiency virus infection]. Enferm Infecc Microbiol Clin 2012;30(8): 472-8
12. Podlekareva DN, Reekie J, Mocroft A, et al. Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study. BMC Infect Dis 2012;12:229
13. Dombrowski JC, Kitahata MM, Van Rompaey SE, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr 2013;63(3):299-306
14. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52(6):793-800
15. Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med 2013;173(14):1337-44
16. Nosyk B, Montaner JS, Colley G, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis 2014;14(1):40-9
17. Amico KR, Zuniga JM, Wilson IB, et al. Provider guidance for linking patients to antiretroviral therapy adherence interventions: recommendations from an IAPAC advisory committee on adherence monitoring and support. J Int Assoc Provid AIDS Care 2013;12(2):79-83
18. Zuniga JM, Young B. Achieving improvements across the HIV treatment cascade: a clinical management algorithm based on IAPAC's entry into and retention in care and antiretroviral therapy adherence guidelines. J Int Assoc Provid AIDS Care 2013;12(1):15-17
19. Hill A. Optimizing HIV treatment. Curr Opin HIV AIDS 2013;8(1):34-40
20. Wandeler G, Keiser O, Hirschel B, et al. A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS ONE 2011;6(12): e27903